help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giudice, L. C.
Right arrow Articles by Irwin, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giudice, L. C.
Right arrow Articles by Irwin, J. C.

Journal of Clinical Endocrinology & Metabolism, Vol 72, 779-787, Copyright © 1991 by Endocrine Society


ARTICLES

Insulin-like growth factor binding proteins in human endometrium: steroid-dependent messenger ribonucleic acid expression and protein synthesis

LC Giudice, DA Milkowski, G Lamson, RG Rosenfeld and JC Irwin
Departments of Gynecology and Obstetrics, Stanford University Medical Center, California 94305.

The insulin-like growth factor (IGF) autocrine/paracrine system is believed to play a role in endometrial differentiation and trophoblast growth. The IGFs bind with high affinity to a family of binding proteins (IGFBPs) that regulate the actions of the IGFs at their target cells. IGFBP-1, one of three well-characterized IGFBPs in humans, has been shown by numerous investigators to be present in secretory but not proliferative endometrium; however, no information is available with regard to two other human IGFBPs, IGFBP-2 and IGFBP-3, in normal human endometrium. We have examined expression of the messenger RNAs (mRNAs) encoding IGFBP-2 and IGFBP-3 in human proliferative endometrium [under the influence of estradiol (E2)] compared to secretory endometrium (under the influence of E2 and progesterone). Using a complementary DNA probe specific for IGFBP-2, by Northern analysis, expression of a 1.4 kilobase mRNA was found to be differentially expressed in secretory compared to proliferative phase endometrium. Using a complementary DNA probe encoding IGFBP-3, a 2.4 kilobase mRNA was found in endometrium and was also found to be differentially expressed in secretory compared to proliferative phase endometrium. Endometrial stromal cells were established in culture and revealed constitutive synthesis and secretion of IGFBP-2 and IGFBP-3 into the conditioned medium (CM), as detected by Western ligand blot analysis of the CM. Identification of the IGFBPs in the CM was made using IGFBP-2 and IGFBP-3 specific antiserum. In the presence of E2 and progesterone, there was an enhancement in the amount of IGFBP-3 and a marked enhancement of IGFBP- 2 in the conditioned media, suggesting sex steroid-dependence of IGFBP- 2 and, to a lesser extent, IGFBP-3 protein synthesis. Western ligand blot analysis of IGFBPs in serum throughout the menstrual cycle revealed no hormonal dependence in the serum IGFBPs, suggesting local action of the IGFBPs in endometrium. These data thus show that mRNAs encoding IGFBP-2 and IGFBP-3 are expressed in human endometrium, that their expression is differentially regulated in secretory compared to proliferative phase endometrium (different steroidogenic environments), and that the synthesis of both IGFBP-2 and IGFBP-3 proteins is regulated by steroid hormones.


This article has been cited by other articles:


Home page
Reproductive SciencesHome page
N. S. Macklon, M. H. van der Gaast, A. Hamilton, B. C. J. M. Fauser, and L. C. Giudice
The Impact of Ovarian Stimulation With Recombinant FSH in Combination With GnRH Antagonist on the Endometrial Transcriptome in the Window of Implantation
Reproductive Sciences, April 1, 2008; 15(4): 357 - 365.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Q. Li, A. Kannan, W. Wang, F. J. DeMayo, R. N. Taylor, M. K. Bagchi, and I. C. Bagchi
Bone Morphogenetic Protein 2 Functions via a Conserved Signaling Pathway Involving Wnt4 to Regulate Uterine Decidualization in the Mouse and the Human
J. Biol. Chem., October 26, 2007; 282(43): 31725 - 31732.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
K. R. Brown, R. D. Goodband, M. D. Tokach, S. S. Dritz, J. L. Nelssen, J. E. Minton, J. J. Higgins, J. C. Woodworth, and B. J. Johnson
Growth characteristics, blood metabolites, and insulin-like growth factor system components in maternal tissues of gilts fed L-carnitine through day seventy of gestation
J Anim Sci, July 1, 2007; 85(7): 1687 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Tulac, M. T. Overgaard, A. E. Hamilton, N. L. Jumbe, E. Suchanek, and L. C. Giudice
Dickkopf-1, an Inhibitor of Wnt Signaling, Is Regulated by Progesterone in Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1453 - 1461.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C.A. White, E. Dimitriadis, A.M. Sharkey, and L.A. Salamonsen
Interleukin-11 inhibits expression of insulin-like growth factor binding protein-5 mRNA in decidualizing human endometrial stromal cells
Mol. Hum. Reprod., September 1, 2005; 11(9): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. C.J.P. Gielen, E. E. Hanekamp, L. J. Blok, F. J. Huikeshoven, and C. W. Burger
Steroid-Modulated Proliferation of Human Endometrial Carcinoma Cell Lines: Any Role for Insulin-like Growth Factor Signaling?
Reproductive Sciences, January 1, 2005; 12(1): 58 - 64.
[Abstract] [PDF]


Home page
EndocrinologyHome page
L. C. Kao, S. Tulac, S. Lobo, B. Imani, J. P. Yang, A. Germeyer, K. Osteen, R. N. Taylor, B. A. Lessey, and L. C. Giudice
Global Gene Profiling in Human Endometrium during the Window of Implantation
Endocrinology, June 1, 2002; 143(6): 2119 - 2138.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Popovici, M. Lu, S. Bhatia, G. H. Faessen, A. J. Giaccia, and L. C. Giudice
Hypoxia Regulates Insulin-Like Growth Factor-Binding Protein 1 in Human Fetal Hepatocytes in Primary Culture: Suggestive Molecular Mechanisms for in Utero Fetal Growth Restriction Caused by Uteroplacental Insufficiency
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2653 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. J. Lockwood, G. Krikun, R. Runic, L. B. Schwartz, A. F. Mesia, and F. Schatz
Progestin-Epidermal Growth Factor Regulation of Tissue Factor Expression during Decidualization of Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 297 - 301.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. I. Tazuke, N. M. Mazure, J. Sugawara, G. Carland, G. H. Faessen, L.-F. Suen, J. C. Irwin, D. R. Powell, A. J. Giaccia, and L. C. Giudice
Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia
PNAS, August 18, 1998; 95(17): 10188 - 10193.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. M. Ohleth, J. A. Lenhart, P. L. Ryan, S. V. Radecki, and C. A. Bagnell
Relaxin Increases Insulin-Like Growth Factors (IGFs) and IGF-Binding Proteins of the Pig Uterus in Vivo
Endocrinology, September 1, 1997; 138(9): 3652 - 3658.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. J. Lockwood and F. Schatz
A Biological Model for the Regulation of Peri-Implantational Hemostasis and Menstruation
Reproductive Sciences, July 1, 1996; 3(4): 159 - 165.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society